World leader in dental and oral reconstruction products selects Global 2.0 to manage its medical products approvals and submissions worldwide.
Framingham, MA, June 10, 2005 – clinivation, Inc. announced today that Implant Innovations, Inc. (3i) has selected clinivation Global™ 2.0 software.
“We are pleased that 3i has selected clinivation Global 2.0 to help build and track their product approvals in the dental and oral reconstruction markets,” said Joseph Kozikowski, M.D., clinivation’s Founder, Chairman, and Chief Executive Officer. “Industry leaders clearly see the value in automating their approval process,” he continued.
Clinivation Global 2.0 software enables medical device companies to sell more products to more countries faster and easier than ever before. Global 2.0 is the first complete solution targeted at automating the business processes for medical device approvals worldwide.
About Implant Innovations, Inc. (3i)
Implant Innovations (3i) designs, manufactures and markets a comprehensive line of dental products which offer an alternative to crowns and bridges for patients. Headquartered in Palm Beach Gardens, Florida, with operations throughout the world, 3i is one of the leading companies in the oral reconstruction market.
For more information about 3i, visit the company website at www.3implant.com
